National Health Investors, Inc. (NHI)

51.6 1.28%
May 28 close; Powered by Koyfin
Pros
Stock price low relative to the 52-week range
Forward dividend yield higher than the industry and sector averages
Forward P/E ratio low relative to industry peers
Forward PEG ratio low relative to industry peers
Average analyst stock price above current stock price
Cons
Revenue growth lower than the industry and sector averages
Company’s profitability is declining
High short share of float
High short interest

Pros

  1. NHI stock price ($49.36) is close to the 52-week low ($48.25). Perhaps now is a good time to buy? See NHI price chart.
  2. NHI forward dividend yield is 7.19%, higher than the industry (3.48%) and sector (1.12%) forward dividend yields. See NHI forward dividend chart.
  3. NHI forward P/E ratio is 13.94, which is low compared to its industry peers’ P/E ratios. See NHI forward P/E ratio chart.
  4. NHI PEG ratio (P/E adjusted for growth) is 0.53, which is low compared to its industry peers’ PEG ratios. See NHI PEG chart.
  5. NHI average analyst price target ($64.83) is above its current price ($49.36). See NHI price target chart.

Cons

  1. NHI quarterly revenue growth was 0.40%, lower than the industry and sector average revenue growth (8.05% and 5.21%, respectively). See NHI revenue growth chart.
  2. NHI profitability is declining. The YoY profit margin change was -5.10 percentage points. See NHI profitability chart.
  3. NHI short share of float is 3.39%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See NHI short share of float chart.
  4. NHI short interest (days to cover the shorts) ratio is 4.42. The stock garners more short interest than the average industry, sector or S&P 500 stock. See NHI short interest ratio chart.